bibliographicCitation |
van Hes R, Smid P, Stroomer CNJ, Tipker K, Tulp MTM, van der Heyden JAM, McCreary AC, Hesselink MB, Kruse CG. SLV310, a novel, potential antipsychotic, combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition. Bioorganic & Medicinal Chemistry Letters. 2003 Feb;13(3):405–8. doi: 10.1016/s0960-894x(02)00996-4. |